These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10776948)

  • 1. Prevalence of hepatitis G virus in healthy children in liver disease, and human immunodeficiency virus-1 infection: response to interferon.
    Infante D; Pich M; Tormo R; Sauleda S; Montané C; Esteban JI; Esteban R
    J Pediatr Gastroenterol Nutr; 2000 Apr; 30(4):385-90. PubMed ID: 10776948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hepatitis G virus coinfection on severity of hepatitis C: relationship to risk factors and response to interferon treatment.
    Lin R; Dutta U; Kaba S; Kench J; Crewe E; Coverdale S; Byth K; Liddle C; Farrell GC
    J Gastroenterol Hepatol; 1998 Aug; 13(8):773-80. PubMed ID: 9736169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GBV-C/HGV infection in children with chronic hepatitis C.
    Komatsu H; Fujisawa T; Inui A; Sogo T; Morinishi Y; Miyagawa Y; Inui M
    J Med Virol; 1999 Oct; 59(2):154-9. PubMed ID: 10459149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of hepatitis G virus/GB virus C replication in liver during and after interferon therapy in patients coinfected with hepatitis C and G viruses.
    Shindo M; Arai K; Okuno T
    J Gastroenterol; 1999 Dec; 34(6):680-7. PubMed ID: 10588184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of GB virus C/hepatitis G virus ribonucleic acid and anti-hepatitis G virus-E2 antibodies among Japanese children with histories of transfusions or with liver diseases.
    Goto K; Sugiyama K; Li R; Miyake Y; Ando T; Mizutani F; Terabe K; Mizuno K; Wada Y
    Pediatr Res; 1999 Jan; 45(1):128-32. PubMed ID: 9890620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.
    Martinot M; Marcellin P; Boyer N; Detmer J; Pouteau M; Castelnau C; Degott C; Aupérin A; Collins M; Kolberg J; Wilber J; Benhamou JP; Erlinger S
    Ann Intern Med; 1997 Jun; 126(11):874-81. PubMed ID: 9163288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease.
    Pramoolsinsap C; Poovorawan Y; Sura T; Theamboonlers A; Busagorn N; Kurathong S
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):480-90. PubMed ID: 10437943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy.
    Hofer H; Aydin I; Neumueller-Guber S; Mueller C; Scherzer TM; Staufer K; Steindl-Munda P; Wrba F; Ferenci P
    J Viral Hepat; 2011 Jul; 18(7):513-7. PubMed ID: 20565572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis G virus RNA in human immunodeficiency virus type 1-positive intravenous drug users.
    Zehender G; De Maddalena C; Bosisio AB; Gianotto M; Santambrogio S; Moroni M; Galli M
    J Hum Virol; 1998; 1(2):96-100. PubMed ID: 10195238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-alpha therapy.
    Yu ML; Chuang WL; Dai CY; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
    Antiviral Res; 2001 Dec; 52(3):241-9. PubMed ID: 11675141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis G virus in hepatitis C virus (HCV)-infected patients and in HCV-contaminated intravenous immunoglobulin products.
    Farshid M; Mitchell F; Biswas R; Ndimbie OK; Ding M
    J Viral Hepat; 1997; 4(6):415-9. PubMed ID: 9430362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coinfection with hepatitis G virus in chronic hepatitis C. Response to treatment with interferon alpha].
    Quintero D; Salmerón J; Palacios A; Muñoz de Rueda P; Torres C; Rodríguez L; Caballero T; Ruiz Extremera A
    Med Clin (Barc); 2000 May; 114(19):726-9. PubMed ID: 10919125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV.
    Lau JY; Qian K; Detmer J; Collins ML; Orito E; Kolberg JA; Urdea MS; Mizokami M; Davis GL
    J Infect Dis; 1997 Aug; 176(2):421-6. PubMed ID: 9237707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure.
    Bourlet T; Guglielminotti C; Evrard M; Berthelot P; Grattard F; Frésard A; Lucht FR; Pozzetto B
    J Med Virol; 1999 Aug; 58(4):373-7. PubMed ID: 10421404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hepatitis G virus infection on chronic hepatitis C.
    Tanaka E; Alter HJ; Nakatsuji Y; Shih JW; Kim JP; Matsumoto A; Kobayashi M; Kiyosawa K
    Ann Intern Med; 1996 Nov; 125(9):740-3. PubMed ID: 8929008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease.
    Tagger A; Ribero ML; Larghi A; Donato F; Zuin M; Chiesa R; Benetti G; Ramella G; Borzio M; Podda M
    Am J Gastroenterol; 1999 Feb; 94(2):484-8. PubMed ID: 10022651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam.
    Kakumu S; Sato K; Morishita T; Trinh KA; Nguyen HB; Banh VD; Do HC; Nguyen HP; Nguyen VT; Le TT; Yamamoto N; Nakao H; Isomura S
    J Med Virol; 1998 Apr; 54(4):243-8. PubMed ID: 9557289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C.
    Brandhagen DJ; Gross JB; Poterucha JJ; Charlton MR; Detmer J; Kolberg J; Gossard AA; Batts KP; Kim WR; Germer JJ; Wiesner RH; Persing DH
    Am J Gastroenterol; 1999 Apr; 94(4):1000-5. PubMed ID: 10201473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy.
    Sáiz JC; Ampurdanés S; Olmedo E; López-Labrador FX; Forns X; Guilera M; Tassies D; Costa J; Sánchez-Tapias JM; Jiménez de Anta MT; Rodés J
    J Hepatol; 1997 Apr; 26(4):787-93. PubMed ID: 9126790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.